Search or

𝛼SK

ENTITY

OBI Pharma Inc (4174 TT)

6

Analysis

Health Care • Taiwan

OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.

more

Refresh

Exchange Announcement • 19 Dec 2025 14:32

The Company’S Bod Resolved To Enter Into Commercial Licensing Agreement With Tegmine For The Development Of Glycoprotein Monoclonal Antibody Adc

Exchange Announcement • 19 Dec 2025 14:32

Announcement Of Bod’S Resolution To Lift The Non-Competition Restrictions For Managerial Officer

Exchange Announcement • 19 Dec 2025 14:31

Announcement Pursuant To Article 22.1 (3) Of The Regulations Governing Loaning Of Funds And Making Of Endorsements/Guarantees By Public Companies

Exchange Announcement • 17 Dec 2025 14:30

Announcement On Behalf Of Amaran That Its Bod Has Elected Dr. Heidi Wang To Serve As Chairperson Of The Board And Concurrently As General Manager

Exchange Announcement • 09 Dec 2025 14:33

Announcement On Behalf Of Amaran The Resignation Of Director

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.60.3

x